Mangoceuticals Announced Significant Progress In Its Ongoing H1N1 Efficacy Study Conducted By Vipragen Biosciences, An AAALAC-accredited Preclinical Cro In Mysuru, India, On Its Patented Respiratory Illness Prevention Technology In Collaboration With Intramont Technologies, Inc.
Author: Benzinga Newsdesk | February 06, 2025 08:12am